Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.jfllifesciences.com | |
Market Cap | 47.29 Cr. | |
Enterprise Value(EV) | 54.28 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.55 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 16.83 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 38.52 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 29.34 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.47 | Calculated using Price: 43.00 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.10 Cr. | 10,998,441 Shares |
FaceValue | 10 | |
About JFL Life Sciences Ltd. | ||
JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS). |
1 Day |
|
-3.37% |
1 Week |
|
-0.23% |
1 Month |
|
-12.16% |
3 Month |
|
-18.02% |
6 Month |
|
+0.94% |
1 Year |
|
+17.81% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 6.03 | 6.94 | 8.85 | 30.94 | 12.90 | |
Return on Capital Employed (%) | 8.71 | 11.80 | 10.32 | 23.14 | 15.44 | |
Return on Assets (%) | 1.87 | 1.78 | 2.03 | 7.27 | 5.77 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 5 | 5 | 7 | 11 | 32 | 34 | |
Non Curr. Liab. | 3 | 1 | 8 | 9 | 2 | 1 | |
Curr. Liab. | 8 | 18 | 14 | 28 | 15 | 18 | |
Minority Int. | |||||||
Equity & Liab. | 16 | 24 | 29 | 48 | 49 | 53 | |
Non Curr. Assets | 3 | 6 | 9 | 9 | 8 | 8 | |
Curr. Assets | 14 | 18 | 20 | 39 | 41 | 46 | |
Misc. Exp. not W/O | |||||||
Total Assets | 16 | 24 | 29 | 48 | 49 | 53 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 32 | 30 | 33 | 34 | 43 | |
Other Income | 0 | 0 | 1 | 2 | ||
Total Income | 32 | 30 | 33 | 34 | 44 | |
Total Expenditure | -30 | -28 | -31 | -28 | -39 | |
PBIDT | 1 | 2 | 2 | 6 | 6 | |
Interest | -1 | -1 | -1 | -2 | -1 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | -1 | -1 | |
Exceptional Items | ||||||
PAT | 0 | 0 | 1 | 3 | 3 | |
Adjusted EPS | 1 | 1 | 1 | 4 | 3 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -3 | 3 | -6 | 2 | -9 | |
Cash Fr. Inv. | -1 | -3 | -2 | -1 | 1 | |
Cash Fr. Finan. | 4 | 0 | 7 | -1 | 8 | |
Net Change | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 |
No Corporate Announcement found. |
Fri, 08 Dec 2023 |
|
|
|
|
|